CHOP is partnering with Abu Dhabi to train scientists from the United Arab Emirates’ capital in its pioneering gene-editing treatments. This marks CHOP’s first overseas partnership specific to ...
Scientists have made many advances using traditional CRISPR technology, especially in medicine, but they are now seeking ways ...
Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...
Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...
13don MSN
A new CRISPR DNA shredder could change gene-editing -- what it means for CRISPR Therapeutics
This new technology could one day significantly expand the market for gene-editing biotechs.
It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...
13don MSN
Gene-edited babies are now closer to becoming a reality. The ethical debate is far from settled
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
The University of California San Diego and the Innovative Genomics Institute (IGI), founded by Nobel laureate and CRISPR gene ...
A major study led by Macquarie University has examined the deep environmental, technological and societal challenges ...
Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.
Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.
Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results